Latest Breaking News On - Ignacio guerrero ros - Page 13 : comparemela.com

Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023

Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesDana farber cancer instituteUniversity of texasDavid schullPatricky wenMike moyerIgnacio guerrero rosAdult brain tumor consortiumJohns hopkins universityCompany quarterly reports on formProfessor of neurology at harvard medical schoolCompany annual report on formGlobal coalition for adaptive researchNational cancer instituteUniversity of texas medical branch at galveston

Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023

Kintara Therapeutics to Host Virtual KOL Event on VAL-083, A Potential First-in-Class Small Molecule Chemotherapeutic for Glioblastoma, on August 21, 2023
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Dana farber cancer instituteUnited statesSan diegoUniversity of texasIgnacio guerrero rosPatricky wenDavid schullMike moyerCompany current reports on formCompany quarterly reports on formMd harvard medical schoolHarvard longwood neurology training programGlobal coalition for adaptive researchCollege of stUniversity of londonProfessor of neurology at harvard medical school

Halia Therapeutics Opens the Doors of its New Headquarters and Laboratory Facilities in Lehi, Utah

/PRNewswire/ Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of diseases driven by.

United statesIgnacio guerrero rosKelvyn cullimoreDavid bearssMike leeCompany contactHalia therapeutics incTolero pharmaceuticalsRusso partnersTraverse mountain blvdTraverse mountainSenator mike leeHalia therapeuticsJames dyeStrategic communication

Kintara Therapeutics to Present at the Emerging Growth Conference

SAN DIEGO, Aug. 9, 2023 /PRNewswire/ Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President.

United statesSan diegoMike moyerDavid schullRoberte hoffmanIgnacio guerrero rosGlobal coalition for adaptive researchNational cancer institutePrnewswire kintara therapeutics incCompany quarterly reports on formCompany current reports on formCompany annual report on formEmerging growth conferenceGlobal coalitionAdaptive researchPrivate securities litigation reform act

Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Initiation of OPERA-01 pivotal Phase 3 monotherapy clinical trial on track; expecting to enroll first patient in fourth quarterNew clinical data for palazestrant to be presented in the fourth quarter.

United kingdomUnited statesSan franciscoSeanp bohenShane kovacsIgnacio guerrero rosAurigene pharmaceuticals the agreementSecurities exchangeBreast cancer annual congressAmerican society of clinical oncologyExchange commissionEuropean society for medical oncologyOlema pharmaceuticals incChief executive officerMedical oncologyClinical oncology